Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 1/2024

02.02.2023 | Originalien

MicroRNA-125b mediates Interferon-γ-induced downregulation of the vitamin D receptor in systemic lupus erythematosus

verfasst von: Yihong Gu, Juan Tang, Hao Zhang, Qiongying Wu, Linjuan Luo, Jian Sun

Erschienen in: Zeitschrift für Rheumatologie | Sonderheft 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

The inflammatory factor interferon (IFN)-γ is related to the occurrence and development of systemic lupus erythematosus (SLE). The vitamin D receptor (VDR) has an anti-inflammatory effect and its downregulation is involved in the onset of SLE. Our previous studies have confirmed that the expression of VDR in SLE peripheral blood mononuclear cells (PBMCs) is downregulated, which is negatively correlated with disease activity and inflammation. However, the mechanism underlying VDR downregulation in SLE is unknown.

Methods

Based on the results of computer simulation analysis, the expression of VDR and four microRNAs (miR-17-3p, miR-34a, miR-346, and miR-125b) in SLE PBMC cells was analyzed under proinflammatory cytokine IFN‑γ treatment, and miR-125b was identified as the target miRNA. The relationship between IFN‑γ, miR-125b, and VDR was further assessed in THP‑1 cells.

Results

We showed that IFN‑γ inhibited the expression of VDR and miR-125b. Further study revealed that VDR mRNA was positively correlated with miR-125b in THP‑1 cells after IFN‑γ intervention. After transfection of miR-125b mimic or inhibitor, the expression of VDR in the miR-125b inhibitor group was lower than in the control group and miR-125b mimic group, while expression in the control group was lower than in miR-125b mimic group. Transfection of miR-125b inhibitor into THP‑1 cells could further promote the ability of IFN‑γ to inhibit VDR.

Conclusion

The decrease in VDR expression promotes development of inflammation and SLE. These data suggest that miR-125b may mediate inflammatory factor IFN-γ-induced downregulation of VDR in the pathogenesis of SLE.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Dong B, Zhou Y, Wang W et al (2020) Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice. Hepatology 71:1559–1574CrossRefPubMed Dong B, Zhou Y, Wang W et al (2020) Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice. Hepatology 71:1559–1574CrossRefPubMed
3.
Zurück zum Zitat Chaiprasongsuk A, Janjetovic Z, Kim TK et al (2020) CYP11A1-derived vitamin D3 products protect against UVB-induced inflammation and promote keratinocytes differentiation. Free Radic Biol Med 155:87–98CrossRefPubMedPubMedCentral Chaiprasongsuk A, Janjetovic Z, Kim TK et al (2020) CYP11A1-derived vitamin D3 products protect against UVB-induced inflammation and promote keratinocytes differentiation. Free Radic Biol Med 155:87–98CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Kellermann L, Jensen KB, Bergenheim F et al (2020) Mucosal vitamin D signaling in inflammatory bowel disease. Autoimmun Rev 19:102672CrossRefPubMed Kellermann L, Jensen KB, Bergenheim F et al (2020) Mucosal vitamin D signaling in inflammatory bowel disease. Autoimmun Rev 19:102672CrossRefPubMed
6.
Zurück zum Zitat Lu R, Zhang YG, Xia Y et al (2021) Paneth cell alertness to pathogens maintained by vitamin D receptors. Gastroenterology 160:1269–1283CrossRefPubMed Lu R, Zhang YG, Xia Y et al (2021) Paneth cell alertness to pathogens maintained by vitamin D receptors. Gastroenterology 160:1269–1283CrossRefPubMed
7.
Zurück zum Zitat Evans RM, Lippman SM (2020) Shining light on the COVID-19 pandemic: a vitamin D receptor checkpoint in defense of unregulated wound healing. Cell Metab 32:704–709CrossRefPubMedPubMedCentral Evans RM, Lippman SM (2020) Shining light on the COVID-19 pandemic: a vitamin D receptor checkpoint in defense of unregulated wound healing. Cell Metab 32:704–709CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Wu XQ, Zhang H, Zhang S et al (2020) Vitamin D receptor is negatively correlated with interferon-γ-inducible protein-10 in systemic lupus erythematosus with renal involvement. Eur J Inflamm 18:1155–1157CrossRef Wu XQ, Zhang H, Zhang S et al (2020) Vitamin D receptor is negatively correlated with interferon-γ-inducible protein-10 in systemic lupus erythematosus with renal involvement. Eur J Inflamm 18:1155–1157CrossRef
9.
Zurück zum Zitat Yi B, Huang J, Zhang W et al (2016) Vitamin D receptor down-regulation is associated with severity of albuminuria in type 2 diabetes patients. J Clin Endocrinol Metab 101:4395–4404CrossRefPubMed Yi B, Huang J, Zhang W et al (2016) Vitamin D receptor down-regulation is associated with severity of albuminuria in type 2 diabetes patients. J Clin Endocrinol Metab 101:4395–4404CrossRefPubMed
10.
Zurück zum Zitat Chen Y, Du J, Zhang Z et al (2014) MicroRNA-346 mediates tumor necrosis factor αinduced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases. Inflamm Bowel Dis 20:1910–1918CrossRefPubMed Chen Y, Du J, Zhang Z et al (2014) MicroRNA-346 mediates tumor necrosis factor αinduced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases. Inflamm Bowel Dis 20:1910–1918CrossRefPubMed
11.
Zurück zum Zitat Sun J, Liu C, Zhang S et al (2019) Vitamin D receptor expression in peripheral blood mononuclear cells is inversely associated with disease activity and inflammation in lupus patients. Clin Rheumatol 38:2509–2518CrossRefPubMed Sun J, Liu C, Zhang S et al (2019) Vitamin D receptor expression in peripheral blood mononuclear cells is inversely associated with disease activity and inflammation in lupus patients. Clin Rheumatol 38:2509–2518CrossRefPubMed
12.
Zurück zum Zitat Liu D, Fang YX, Wu X et al (2019) 1,25-(OH)2D3/Vitamin D receptor alleviates systemic lupus erythematosus by downregulating Skp2 and upregulating p27. Cell Commun Signal 17:163CrossRefPubMedPubMedCentral Liu D, Fang YX, Wu X et al (2019) 1,25-(OH)2D3/Vitamin D receptor alleviates systemic lupus erythematosus by downregulating Skp2 and upregulating p27. Cell Commun Signal 17:163CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Tuller T, Atar S, Ruppin E, Gurevich M et al (2013) Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases. Genes Immun 14:67–82CrossRefPubMed Tuller T, Atar S, Ruppin E, Gurevich M et al (2013) Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases. Genes Immun 14:67–82CrossRefPubMed
14.
Zurück zum Zitat Csiszár A, Nagy G, Gergely P et al (2000) Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL‑4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 122:464–470CrossRefPubMedPubMedCentral Csiszár A, Nagy G, Gergely P et al (2000) Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL‑4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 122:464–470CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Viallard JF, Pellegrin JL, Ranchin V et al (1999) Th1 (IL‑2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 115:189–195CrossRefPubMedPubMedCentral Viallard JF, Pellegrin JL, Ranchin V et al (1999) Th1 (IL‑2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 115:189–195CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Paradowska-Gorycka A, Wajda A, Stypinska B et al (2021) Variety of endosomal TLRs and Interferons (IFN‑α, IFN‑β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD. Clin Exp Immunol 204:49–63CrossRefPubMedPubMedCentral Paradowska-Gorycka A, Wajda A, Stypinska B et al (2021) Variety of endosomal TLRs and Interferons (IFN‑α, IFN‑β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD. Clin Exp Immunol 204:49–63CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Zhang J, Chen C, Fu H et al (2020) MicroRNA-125a-loaded polymeric nanoparticles alleviate systemic lupus erythematosus by restoring effector/regulatory T cells balance. ACS Nano 14:4414–4429CrossRefPubMed Zhang J, Chen C, Fu H et al (2020) MicroRNA-125a-loaded polymeric nanoparticles alleviate systemic lupus erythematosus by restoring effector/regulatory T cells balance. ACS Nano 14:4414–4429CrossRefPubMed
18.
Zurück zum Zitat Xie M, Wang J, Gong W et al (2019) NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3. J Autoimmun 102:96–113CrossRefPubMed Xie M, Wang J, Gong W et al (2019) NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3. J Autoimmun 102:96–113CrossRefPubMed
19.
Zurück zum Zitat Hou G, Harley ITW, Lu X et al (2021) SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression. Nat Commun 12:135ADSCrossRefPubMedPubMedCentral Hou G, Harley ITW, Lu X et al (2021) SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression. Nat Commun 12:135ADSCrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Zhang L, Wu H, Zhao M et al (2020) Clinical significance of miRNAs in autoimmunity. J Autoimmun 109:102438CrossRefPubMed Zhang L, Wu H, Zhao M et al (2020) Clinical significance of miRNAs in autoimmunity. J Autoimmun 109:102438CrossRefPubMed
21.
Zurück zum Zitat Aringer M, Costenbader K, Daikh D et al (2019) 2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78:1151–1159CrossRefPubMed Aringer M, Costenbader K, Daikh D et al (2019) 2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78:1151–1159CrossRefPubMed
22.
Zurück zum Zitat Abdel Galil SM, Ezzeldin N, El-Boshy ME (2015) The role of serum IL-17 and IL‑6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis. Cytokine 76:280–287CrossRefPubMed Abdel Galil SM, Ezzeldin N, El-Boshy ME (2015) The role of serum IL-17 and IL‑6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis. Cytokine 76:280–287CrossRefPubMed
23.
24.
Zurück zum Zitat Zhang Y, Niu L, Wang F et al (2022) Vitamin D receptor expression in SLE peripheral blood CD4+T cells is associated with disease activity and cell apoptosis. Mod Rheumatol 32:577–583CrossRefPubMed Zhang Y, Niu L, Wang F et al (2022) Vitamin D receptor expression in SLE peripheral blood CD4+T cells is associated with disease activity and cell apoptosis. Mod Rheumatol 32:577–583CrossRefPubMed
25.
Zurück zum Zitat Zhang WT, Jin TF, Chen L (2020) Associations of four common VDR polymorphisms with rheumatoid arthritis and systemic lupus erythematosus: evidence from a meta-analysis. Lupus 29:364–370CrossRefPubMed Zhang WT, Jin TF, Chen L (2020) Associations of four common VDR polymorphisms with rheumatoid arthritis and systemic lupus erythematosus: evidence from a meta-analysis. Lupus 29:364–370CrossRefPubMed
26.
Zurück zum Zitat Barrat FJ, Crow MK, Ivashkiv LB (2019) Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol 20:1574–1583CrossRefPubMedPubMedCentral Barrat FJ, Crow MK, Ivashkiv LB (2019) Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol 20:1574–1583CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Chatham WW, Furie R, Saxena A et al (2021) Long-term safety and efficacy of anifrolumab in adults with systemic lupus erythematosus: results of a phase II openlabel extension study. Arthritis Rheumatol 73:816–825CrossRefPubMedPubMedCentral Chatham WW, Furie R, Saxena A et al (2021) Long-term safety and efficacy of anifrolumab in adults with systemic lupus erythematosus: results of a phase II openlabel extension study. Arthritis Rheumatol 73:816–825CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Ding Y, Liao W, He XJ et al (2017) Effects of 1,25(OH)2D3 and vitamin D receptor on peripheral CD4+ /CD8+ double-positive T lymphocytes in a mouse model of systemic lupus erythematosus. J Cell Mol Med 21:975–985CrossRefPubMedPubMedCentral Ding Y, Liao W, He XJ et al (2017) Effects of 1,25(OH)2D3 and vitamin D receptor on peripheral CD4+ /CD8+ double-positive T lymphocytes in a mouse model of systemic lupus erythematosus. J Cell Mol Med 21:975–985CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Latini A, De Benedittis G, Perricone C et al (2021) VDR polymorphisms in autoimmune 11 connective tissue diseases: focus on Italian population. J Immunol Res 2021:5812136CrossRefPubMedPubMedCentral Latini A, De Benedittis G, Perricone C et al (2021) VDR polymorphisms in autoimmune 11 connective tissue diseases: focus on Italian population. J Immunol Res 2021:5812136CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Liu W, Li M, Wang Z et al (2020) IFN‑γ mediates the development of systemic lupus erythematosus. Biomed Res Int 2020:7176515PubMedPubMedCentral Liu W, Li M, Wang Z et al (2020) IFN‑γ mediates the development of systemic lupus erythematosus. Biomed Res Int 2020:7176515PubMedPubMedCentral
31.
Zurück zum Zitat Wen S, He F, Zhu X et al (2018) IFN‑γ, CXCL16, uPAR: potential biomarkers for systemic lupus erythematosus. Clin Exp Rheumatol 36:36–43PubMed Wen S, He F, Zhu X et al (2018) IFN‑γ, CXCL16, uPAR: potential biomarkers for systemic lupus erythematosus. Clin Exp Rheumatol 36:36–43PubMed
32.
Zurück zum Zitat Cao W, Qian G, Luo W et al (2018) miR-125b is downregulated in systemic lupus erythematosus patients and inhibits autophagy by targeting UVRAG. Biomed Pharmacother 99:791–797CrossRefPubMed Cao W, Qian G, Luo W et al (2018) miR-125b is downregulated in systemic lupus erythematosus patients and inhibits autophagy by targeting UVRAG. Biomed Pharmacother 99:791–797CrossRefPubMed
33.
Zurück zum Zitat Li X, Kroin JS, Kc R et al (2013) Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints. J Bone Miner Res 28:2512–2522CrossRefPubMed Li X, Kroin JS, Kc R et al (2013) Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints. J Bone Miner Res 28:2512–2522CrossRefPubMed
34.
Zurück zum Zitat Zhao X, Tang Y, Qu B et al (2010) MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum 62:3425–3435CrossRefPubMed Zhao X, Tang Y, Qu B et al (2010) MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum 62:3425–3435CrossRefPubMed
35.
Zurück zum Zitat Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318:1931–1934ADSCrossRefPubMed Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318:1931–1934ADSCrossRefPubMed
36.
Zurück zum Zitat Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–114CrossRefPubMed Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–114CrossRefPubMed
Metadaten
Titel
MicroRNA-125b mediates Interferon-γ-induced downregulation of the vitamin D receptor in systemic lupus erythematosus
verfasst von
Yihong Gu
Juan Tang
Hao Zhang
Qiongying Wu
Linjuan Luo
Jian Sun
Publikationsdatum
02.02.2023
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe Sonderheft 1/2024
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-023-01319-4

Weitere Artikel der Sonderheft 1/2024

Zeitschrift für Rheumatologie 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.